Unilever CEO retires , replaced by insider Jope
LONDON: Unilever's Chief Executive Paul Polman will step down next month after 10 years in the job, leaving insider Alan Jope to step into his shoes after the Anglo-Dutch group's failed attempt to shift its headquarters.
A UK investor revolt forced Polman and the Unilever board to scrap a plan in October to move the headquarters of the dual-listed company, which makes Dove soap and Ben & Jerry's ice cream, to the Netherlands.
Company veteran Jope, 54, is the boss of the beauty and personal care division which is Unilever's largest, accounting for almost half of group annual profits. The Scotsman also previously led the company's business in China and has long been seen as a possible successor to Polman.
"Our global footprint includes strong positions in many important markets for the future and our focus will remain on serving our consumers, and our other multiple stakeholders, to deliver long‐term growth and value creation," Jope said.
At the helm since January 2009, Polman, 62, generated big returns for shareholders totalling 290 per cent over the period, expanded its presence in emerging markets, and in 2017 fended off a $143 billion takeover approach by Kraft-Heinz.
That failed bid, however, helped prompt Dutchman Polman to seek to simplify Unilever's structure by shifting its headquarters to Rotterdam. That angered UK-based shareholders as Unilever would have left the UK FTSE 100 share index, forcing some to sell.
Unilever's board, led by Chairman Marijn Dekkers, ditched the HQ move plan on Oct. 5 after it became clear that it could fall short of the investor approval needed.
Dekkers denied the row had accelerated Polman's retirement.
"The appointment of Alan Jope as the successor of Paul has nothing to do with the simplification process," he told reporters on Thursday.
Polman's decision to retire was not unexpected and the board had started a process a year ago to consider appropriate replacements, Dekkers added.
"That's why we were able to appoint Alan immediately," he said.
MARMITE
Polman's reputation as a champion of issues like sustainability and the company's social impact wasn't always appreciated. Bernstein analyst Andrew Wood said some investors were irked by what they considered a "preachy" style but added that Polman had a strong record over the past decade.
"Just like one of Unilever's highest-profile products, Marmite, Polman engenders strongly differing opinions from investors," Wood said.
"We consider that Polman has been an exceptionally good CEO of Unilever," Wood added.
Dekkers said that Jope's appointment "stands for continuity", reassuring investors that the company was on track to meet guidelines set by Polman, that includes a target for an underlying operating margin of 20 per cent by 2020.
Unilever investor Skagen Global Fund said it hoped that Jope would build on Polman's legacy.
"Jope is an impressive executive and we congratulate the board on an excellent choice of successor," Skagen Global fund portfolio manager Knut Gezelius said.
"Choosing Jope over presumably a long list of strong external candidates is another testament to the strength of the internal bench and management quality at Unilever."
NATIONAL BALANCE
The appointment of Jope rebalances the Anglo-Dutch leadership of the company in favour of the British-side. While Dekkers is Dutch, Unilever's Chief Financial Officer Graeme Pitkethly is also British.
Dekkers said that nationality played no role in how Unilever made appointment decisions.
Pitkethly, who was involved in the media campaign defending the plan to move the HQ, had also been rumoured as a possible replacement for Polman.
Jope joined Unilever as a graduate trainee in 1985. He will be paid a fixed salary of 1.45 million euros ($1.65 million) plus a target annual bonus of 150 per cent of fixed pay in his new role as CEO.
Investors will not have to wait long for a chance to quiz the company on its future - Unilever is due to hold an investor day in Mumbai, India on Dec. 4 and 5.
On the new CEO's agenda will be Unilever's bid for Glaxo Smith Kline's Indian Horlicks nutrition business, where it is competing against consumer giant Nestle, as well as handling any fallout from a possible no-deal Brexit as Britain is due to leave the EU in March 2019.
Polman, who was paid a fixed annual salary of 1.4 million pounds but with bonuses took home a total package of about 10 million pounds, will stay on for six months to support Jope's transition into the role, Unilever added in its statement.
Shares in Unilever traded 0.2 per cent higher in midafternoon. The stock has risen 170 per cent since Polman took the top job, outperforming Britain's bluechip index which is up about 75 per cent.
Also Read: Unilever emerges as leading bidder for GSK’s Indian Horlicks business: Sources
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd